The Gulbenkian Institute for Molecular Medicine (GIMM) is a leading research institution in Portugal committed to advancing scientific knowledge in health and disease. GIMM fosters an interdisciplinary approach to biomedical research, focusing on understanding molecular and cellular mechanisms that drive various conditions, including cancer, neurological disorders, and infectious diseases. Through cutting-edge technology, collaborative networks, and a commitment to innovation, GIMM aims to translate fundamental discoveries into real-world applications, improving diagnostics, treatments, and overall patient care.